ANOCA,INOCA,MINOCA:冠状动脉综合征的新前沿
Antonio L M Parlati1, Ermanno Nardi1, Vincenzo Sucato2
1Department of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, Italy.
Journal of cardiovascular development and disease
|February 25, 2025
概括
不阻塞冠状动脉缺血 (INOCA),不阻塞冠状动脉心痛 (ANOCA) 和不阻塞冠状动脉心肌梗塞 (MINOCA) 越来越多地被诊断出. 这些情况,一旦被认为是良性的,可以导致严重的心血管事件和残疾.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 血管生物学 血管生物学
背景情况:
- 越来越多的INOCA,ANOCA和MINOCA诊断需要对其临床意义进行重新评估.
- 这些以前被低估的综合征现在被认为是严重心血管事件和长期残疾的潜在原因.
- 非阻塞性冠状动脉疾病 (CAD) 可能比阻塞性CAD更为普遍,需要进一步调查.
研究的目的:
- 为了澄清INOCA,ANOCA和MINOCA背后的复杂和异质的致病机制.
- 识别和分析与这些非阻塞性冠状动脉疾病综合征相关的风险因素.
- 总结诊断策略和基于证据的干预和药理疗法.
主要方法:
- 专注于致病机制,风险因素,INOCA,ANOCA和MINOCA的诊断和治疗的文献综述.
- 关于非阻塞性冠状动脉疾病的临床相关性和管理的当前证据的综合.
- 基于最新研究的诊断途径和治疗方法的分析.
主要成果:
- 新出现的证据表明,INOCA,ANOCA和MINOCA与显著的心血管风险和长期患者残疾有关.
- 非阻塞性CAD的患病率似乎很大,挑战了对冠状动脉疾病的传统观点.
- 了解异质机制和风险因素对于准确的诊断和有效的管理至关重要.
结论:
- 在心脏病学中,INOCA,ANOCA和MINOCA代表了一个显著且日益增长的临床挑战.
- 对潜在机制和风险分层的进一步研究对于改善患者的治疗结果至关重要.
- 准确的诊断和量身定制的治疗干预措施对于管理非阻塞性冠状动脉疾病患者至关重要.
更多相关视频
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
4.8K
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
3.8K
相关概念视频
01:21Coronary Circulation
2.1K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
2.1K
01:17Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
437
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
437
01:11Overview of Systemic Arteries
755
The human body is a complex, well-organized machine, and at the heart of its operations lies the circulatory system. This network of blood vessels, which includes systemic arteries, plays a vital role in maintaining life by transporting nutrients, oxygen, and waste products to and from cells throughout the body.
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
Systemic circulation is the part of the cardiovascular system that carries oxygenated blood away from the heart to the body's tissues and returns deoxygenated blood back to the...
755
01:16Antianginal Drugs: Nitrates and β-Blockers
495
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
495
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K